Research Associate I/II, Discovery Analytics
BlueRock Therapeutics
Summary
We are seeking a motivated Research Associate I/II to join our Discovery Analytics team. In this laboratory-based role, the candidate will apply molecular, cellular, biochemical, and imaging-based methods to characterize the identity, phenotype, purity, and function of cell therapy products and process intermediates.
Job description
The successful candidate will work closely with Discovery Analytics scientists and cross-functional program teams to execute analytical studies, evaluate data quality, troubleshoot assays, and improve methods as research programs advance. The position may be filled at the RA I or RA II level based on education, relevant experience, technical proficiency, and demonstrated independence.
Key Responsibilities
- Execute analytical testing to support cell therapy research, process development, and product characterization.
- Perform assays including flow cytometry, qPCR/ddPCR, ELISA and other immunoassays, microscopy, image analysis, and cell-based functional assays.
- Support method development, optimization, qualification, and troubleshooting through well-controlled experimental studies.
- Analyze and interpret experimental data, evaluate assay performance and controls, and communicate scientifically sound conclusions to project teams.
- Maintain clear, accurate, and traceable records of samples, methods, raw data, analyses, and experimental outcomes.
- Coordinate sample testing and experimental timelines across multiple programs in collaboration with multidisciplinary teams.
- Maintain instruments, reagents, controls, and laboratory supplies while following established safety and quality practices.
- Contribute to the evaluation and implementation of new analytical technologies, automation, and standardized workflows.
Qualifications
- Research Associate I: BS in biology, cell biology, molecular biology, biochemistry, bioengineering, biotechnology, or a related field, with 0+ years of relevant experience.
- Research Associate II: BS in a relevant scientific discipline with 2+ years of relevant experience, or MS in a relevant scientific discipline with 0+ years of relevant experience.
- Mammalian cell culture, particularly stem cell-derived or primary cell systems
- Flow cytometry; qPCR and/or ddPCR; ELISA or other protein-based assays
- Microscopy, quantitative image analysis, and cell-based functional assays
- Quantitative analysis of biological data and clear presentation of results
- Assay development, optimization, qualification, or troubleshooting
- Laboratory automation and automated liquid handling platforms for assay execution and higher-throughput sample processing
- Cell therapy, iPSC-derived products, or analytical development in a research environment
Requirements
- BS in biology, cell biology, molecular biology, biochemistry, bioengineering, biotechnology, or a related field (RA I)
- BS in a relevant scientific discipline with 2+ years of relevant experience, or MS in a relevant scientific discipline (RA II)
- Mammalian cell culture, particularly stem cell-derived or primary cell systems
- Flow cytometry; qPCR and/or ddPCR; ELISA or other protein-based assays
- Microscopy, quantitative image analysis, and cell-based functional assays
- Quantitative analysis of biological data and clear presentation of results
- Assay development, optimization, qualification, or troubleshooting
- Laboratory automation and automated liquid handling platforms
- Cell therapy, iPSC-derived products, or analytical development in a research environment
Company overview
BlueRock Therapeutics is a clinical-stage biotechnology company pioneering engineered cell therapies for the treatment of devastating neurological and ophthalmic diseases. Founded in 2016 as a joint venture between Versant Ventures and Leaps by Bayer, the company became a wholly owned, independently operated subsidiary of Bayer AG in late 2019. BlueRock leverages its proprietary induced pluripotent stem cell (iPSC) platform to develop novel cellular medicines that aim to transform disease treatment through regenerative approaches. The company's pipeline includes two clinical-stage programs: bemdaneprocel (BRT-DA01) for Parkinson's disease and OpCT-001 for primary photoreceptor diseases affecting vision. With operations spanning Cambridge, Massachusetts; Toronto, Ontario; New York; and Berlin, BlueRock employs 201-500 professionals dedicated to advancing cell and gene therapies. The company's mission centers on harnessing the power of cell therapy to create breakthrough medicines for patients with limited treatment options, operating at the intersection of neurology, cardiology, and immunology research.